Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RAAR vs. PAAA: which is better?

Bottom line

RAAR vs PAAA: the short answer

RAAR (Reckoner Yield Enhanced AAA CLO Reinvesting ETF) and PAAA (Pgim Aaa Clo ETF) are both etfs.

But PAAA is far broader, holding 330 positions to 2 for RAAR, so beyond the top names it adds exposure RAAR doesn't have.

Updated Nov 19, 2026

RAAR vs PAAA side by side

RAARPAAA
TypeETFETF
Fund familyTortoisePGIM (Prudential)
CategoryLarge BlendBank Loan / Floating Rate
Expense ratio—0.19%
Annual cost per $10k—$19
10-yr cost on $10k (prospectus)—$243
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+5.4%
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter—+1.9%
Worst quarter—+1.1%
Net assets (fund)$12.7M$10.2B
Number of holdings2330
Portfolio turnover—35%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

RAAR and PAAA share none of their top holdings.

RAAR top 10

  1. Reckoner Yield Enhanced AAA CL — 99.09%
  2. U.S. Bank Money Market Deposit Account — 0.91%

PAAA top 10

  1. (PIPA070) PGIM Core Government Money Market Fund — 7.64%
  2. Cbamr Ltd — 1.92%
  3. Regatta XXVII Funding Ltd / Regatta XXVII Funding LLC — 1.58%
  4. Elevation Clo 2021-12 Ltd — 1.13%
  5. Octagon Investment Partners 31 Ltd — 1.04%
  6. Cbam 2020-13 Ltd. — 0.99%
  7. Elmwood Clo 25 Ltd — 0.99%
  8. Neuberger Berman Loan Advisers Clo 33 Ltd — 0.96%
  9. Rr 27 Ltd — 0.93%
  10. Agl Clo I Ltd — 0.87%

FAQ

What is the difference between RAAR and PAAA?
RAAR (Reckoner Yield Enhanced AAA CLO Reinvesting ETF) and PAAA (Pgim Aaa Clo ETF) are both etfs. But PAAA is far broader, holding 330 positions to 2 for RAAR, so beyond the top names it adds exposure RAAR doesn't have.
Should I own both RAAR and PAAA?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.